ClinicalTrials.Veeva

Menu

Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)

F

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Status

Unknown

Conditions

Collecting Duct Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT05372302
INT 12/21

Details and patient eligibility

About

  • Collect a large number of samples with certain / suspected diagnosis of collecting duct carcinoma in order to confirm the diagnosis (centralized review) and standardize according to WHO 2016 criteria
  • Build an extensive tissue bank (DNA and RNA extraction) aimed at defining the molecular taxonomy of the tumor through 1) transcriptomic analysis 2) gene expression profile
  • Define specific molecular signatures

Enrollment

100 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Signature of consent (for patients enrolled in the prospective part of the study)
  • Histological diagnosis of renal cell carcinoma of the Bellini collecting duct RCC

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Roberta Mennitto, Dr.ssa; Elena Verzoni, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems